Daniel J. Holder

Cerebrospinal fluid biomarkers distinguish postmortem-confirmed Alzheimer's disease from other dementias and healthy controls in the OPTIMA cohort.

A. Simon, W. Potter, A. Smith, 2015, Journal of Alzheimer's disease : JAD.

Screening for New Biomarkers for Subcortical Vascular Dementia and Alzheimer's Disease

K. Blennow, A. Simon, W. Potter, 2011, Dementia and Geriatric Cognitive Disorders Extra.